Loading clinical trials...
Loading clinical trials...
A Phase Ib Study to Determine the Safety and Immunogenicity of the Candidate Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Vaccine ChAdOx1 MERS in Healthy Adult Middle Eastern Volunteers
Conditions
Interventions
ChAdOx1 MERS
Locations
1
Saudi Arabia
King Abdulaziz Medical City, National Guard Health Affairs
Riyadh, Saudi Arabia
Start Date
December 17, 2019
Primary Completion Date
November 26, 2020
Completion Date
November 26, 2020
Last Updated
December 1, 2020
Lead Sponsor
King Abdullah International Medical Research Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions